Jin Medical International
ZJYL
12 hedge funds and large institutions have $3.17M invested in Jin Medical International in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 9 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
6% more capital invested
Capital invested by funds: $2.98M → $3.17M (+$189K)
0.28% more ownership
Funds ownership: 0.5% → 0.78% (+0.28%)
33% less funds holding
Funds holding: 18 → 12 (-6)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.24M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$230K |
| 3 |
WG
Winton Group
London,
United Kingdom
|
+$158K |
| 4 |
Squarepoint
New York
|
+$105K |
| 5 |
Morgan Stanley
New York
|
+$3.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$734K |
| 2 |
Millennium Management
New York
|
-$293K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$154K |
| 4 |
Jane Street
New York
|
-$135K |
| 5 |
JP Morgan Chase
New York
|
-$81.2K |
ZJYL Hedge Fund Activity: Q2 2024 in Review
12 of the 6,938 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q2 2024, worth a combined $3.17M — up 6.3% from $2.98M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ZJYL and 3 opened new positions — a net loss of 6 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $2.24M. The largest seller was Marshall Wace, exiting entirely with an estimated $734K sold.
- 12 institutional investors held Jin Medical International (ZJYL) as of Q2 2024, down from 18 in Q1 2024.
- Funds reported $3.17M of Jin Medical International stock for Q2 2024, up 6.3% quarter-over-quarter.
- 3 funds opened new Jin Medical International positions in Q2 2024 and 9 closed out, a net change of -6 holders.
- The largest Jin Medical International buyer in Q2 2024 was Vanguard Group, an estimated $2.24M added.
- The largest Jin Medical International seller in Q2 2024 was Marshall Wace, an estimated $734K sold.
Based on aggregated 13F filings for Q2 2024.